The emerging role of PI3K inhibitors for solid tumour treatment and beyond
Carmen Belli, Matteo Repetto, Santosh Anand, Camillo Porta, Vivek Subbiah, Giuseppe Curigliano
Topics & Concepts
PI3K/AKT/mTOR pathwayP110αAllosteric regulationMutantCancer researchPharmacologyBiologyLimitingKinaseMedicineBioinformaticsSignal transductionInternal medicineReceptorCell biologyGeneticsGeneMechanical engineeringEngineeringPI3K/AKT/mTOR signaling in cancerChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia Treatments